Evidence map›Paper›PMID 39013608›Full record

ArticleJournal of industrial microbiology & biotechnology2024

Sustainable production of 2,3,5,6-Tetramethylpyrazine at high titer in engineered Corynebacterium glutamicum.

Aparajitha Srinivasan, Kevin Chen-Xiao, Deepanwita Banerjee, Asun Oka, Venkataramana R Pidatala, Aymerick Eudes, Blake A Simmons, Thomas Eng, Aindrila Mukhopadhyay

Abstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aparajitha SrinivasanJoint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-3511-5014
Kevin Chen-XiaoJoint BioEnergy Institute, Emeryville, CA 94608, USA.
Deepanwita BanerjeeJoint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-0083-0608
Asun OkaBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
Venkataramana R PidatalaJoint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0003-2637-3983
Aymerick EudesJoint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-1387-6111
Blake A SimmonsJoint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-1332-1810
Thomas EngJoint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-4974-3863
Aindrila MukhopadhyayJoint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-6513-7425

Funding

Department of Energy-BioEnergy Technologies Office DE-AC02-05CH11231U.S. Department of Energy
6 · The paper itself

Abstract

The industrial amino acid production workhorse, Corynebacterium glutamicum naturally produces low levels of 2,3,5,6-tetramethylpyrazine (TMP), a valuable flavor, fragrance, and commodity chemical. Here, we demonstrate TMP production (∼0.8 g L-1) in C. glutamicum type strain ATCC13032 via overexpression of acetolactate synthase and/or α-acetolactate decarboxylase from Lactococcus lactis in CGXII minimal medium supplemented with 40 g L-1 glucose. This engineered strain also demonstrated growth and TMP production when the minimal medium was supplemented with up to 40% (v v-1) hydrolysates derived from ionic liquid-pretreated sorghum biomass. A key objective was to take the fully engineered strain developed in this study and interrogate medium parameters that influence the production of TMP, a critical post-strain engineering optimization. Design of experiments in a high-throughput plate format identified glucose, urea, and their ratio as significant components affecting TMP production. These two components were further optimized using response surface methodology. In the optimized CGXII medium, the engineered strain could produce up to 3.56 g L-1 TMP (4-fold enhancement in titers and 2-fold enhancement in yield, mol mol-1) from 80 g L-1 glucose and 11.9 g L-1 urea in shake flask batch cultivation. ONE-SENTENCE SUMMARY: Corynebacterium glutamicum was metabolically engineered to produce 2,3,5,6-tetramethylpyrazine followed by a design of experiments approach to optimize medium components for high-titer production.

Indexed as

Corynebacterium glutamicumCulture MediaGlucoseMetabolic EngineeringPyrazinesAcetolactate SynthaseCarboxy-LyasesLactococcus lactisUreaAcetolactate SynthaseCarboxy-LyasesCulture MediaGlucosePyrazinestetramethylpyrazineUreaC. glutamicumHydrolysateMedium optimizationOverexpressionTMP

Identifiers

PMID39013608
PMCPMC11302136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.